Novo Nordisk aims for 2016 Tresiba launch in U.S

A Novo Nordisk employee controls a machine at an insulin production line in a plant in Kalundborg November 4, 2013. REUTERS/Fabian Bimmer

By Stine Jacobsen and Ole Mikkelsen COPENHAGEN (Reuters) - Novo Nordisk